Earnings Call · Q4 FY2022·2023-03-15

Q4 22EPS +21.74%·Rev n/aQ3 22EPS +8.00%·Rev n/aQ2 22EPS -9.52%·Rev n/aQ1 22EPS -25.00%·Rev n/a⚠ consensus missing

Vaxart, Inc. VXRT

Brant Biehn — Investor Relations or Communications

Andrei Floroiu — Chief Executive Officer

James Cummings — Chief Medical Officer

Sean Tucker — Founder and Chief Science Officer

Phil Lee — Chief Financial Officer

+3.9%1d on move date+2.2% vs SPY3d−6.7%5d−2.7%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more VXRT calls or request research access.

More VXRT calls Browse calls Request research access